| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2836978 | Cardiovascular Revascularization Medicine | 2013 | 5 Pages |
Abstract
The use of platelet reactivity assays to identify patients on thienopyridine therapy at higher risk of bleeding is an unfounded strategy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
Authors
Michael A. Jr., Rebecca Torguson, Shreejana Pokharel, Rajbabu Pakala, Zhenyi Xue, William O. Suddath, Kenneth M. Kent, Lowell F. Satler, Augusto D. Pichard, Ron Waksman,